Back
Business
NEW DELHI: Jubilant Organosys and Eli Lilly on Friday announced a 50:50 joint venture to provide drug development services in the country. The joint venture is expected to commence operations by the end of the current year. © Copyright 2000 - 2009 The Hindu |